1000 Participants Needed

Screening for Mitral Valve Disease

(MVSS Trial)

Recruiting at 16 trial locations
JS
MR
KL
Overseen ByKassandra Lopez
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medstar Health Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines individuals who did not qualify for a treatment to fix a heart valve problem using Transcatheter Mitral Valve Implantation (TMVI). Researchers aim to understand why some individuals cannot receive this treatment and how their heart condition progresses over time. This trial targets those who were ineligible for TMVI due to their heart's structure or other health factors. Individuals screened but not receiving the TMVI procedure may be suitable candidates for this study. As an unphased study, this trial provides a unique opportunity to contribute to research that could enhance future treatment options for heart valve issues.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about the Mitral Valve Screening Survey because it aims to improve how we identify issues with the mitral valve without invasive procedures. Most current methods for diagnosing mitral valve conditions involve echocardiograms or MRIs, which can be costly and time-consuming. This trial is exploring a non-invasive and potentially more accessible way to screen for these heart issues, which could lead to earlier detection and treatment. If successful, this approach could make heart health monitoring more efficient and widespread, benefiting patients who might otherwise go undiagnosed.

Are You a Good Fit for This Trial?

Inclusion Criteria

Subject failed screening for TMVI

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Registry Data Collection

Baseline demographics, anatomical/imaging characteristics, and clinical outcomes of patients who fail screening for TMVI are collected

Ongoing

Follow-up

Participants are monitored for safety and effectiveness after screening failure

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • None

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medstar Health Research Institute

Lead Sponsor

Trials
202
Recruited
187,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security